In a research report published Wednesday, Wedbush analyst Liana Moussatos downgraded shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) from Outperform to Neutral, while reducing the …
Allergan plc Ordinary Shares (NYSE:AGN) announced today that it had entered an agreement to acquire Vitae Pharmaceuticals Inc (NASDAQ:VTAE), a clinical-stage biotech company, …
Vitae Pharmaceuticals Inc (NASDAQ:VTAE) and Allergan plc (NYSE:AGN) announced that they have entered into a definitive agreement under which Allergan will acquire Vitae for $21.00 …
In a research note released Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), while raising the …
Vitae Pharmaceuticals Inc (NASDAQ:VTAE) shares jumped 94% in pre-market trading after the company announced positive top-line results from its experimental psoriasis drug VTP-43742. The …
Vitae Pharmaceuticals, Inc.(NASDAQ:VTAE), a clinical-stage biotechnology company, today announced positive top-line results from its Phase 2a proof-of-concept clinical trial of VTP-43742 in psoriatic …